| Ytd | -38.06% | |
| 1y | -37.32% |
| Open | 9.57 | Prev Close | 9.70 | Low | 9.32 | High | 9.60 | Mkt Cap | 382.48M |
| Vol | 334.69K | Avg Vol | 382.51K | EPS | -1.52 | P/E | N/A | Forward P/E | -1733.00 |
| Beta | 1.05 | Short Ratio | 3.89 | Inst. Own | 92.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 10.65 | 200-d Avg | 12.43 | 1yr Est | 24.40 |
OFIX News
Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration
Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday&
Orthofix Medical NASDAQ: OFIX reported second-quarter results that management said reflected improvi
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Orthofix (OFIX) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Est
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday&#
Orthofix Medical (NASDAQ:OFIX) raises FY2026 sales outlook from $838.000 million-$848.000 million to
Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.07 per share which beat the analyst
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical te
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YO
Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnin
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
The average of price targets set by Wall Street analysts indicates a potential upside of 33.3% in Or
Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refin
The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial executio
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical te
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical te
On April 16, 2026, the U.S. Food and Drug Administration ("FDA") issued a final order reclas
Stocks mixed, Dow falls 100 points. Terawulf Inc (NASDAQ: WULF) rises after lease deal. Other big ga
Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market
Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend
Orthofix Medical Inc. (OFIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YO
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
SHAREHOLDER ALERT: Purcell and Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical
NEW YORK, May 26, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Or
Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and
Get the latest analyst rating changes for top companies on Wall Street, including upgrades and downg
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outpe
Stifel analyst Thomas Stephan maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the
[url="]Orthofix Medical Inc[/url]. (NASDAQ: OFIX), a leading global medical technology company, toda
The Company will highlight these advances at the Pediatric Orthopedic Society of North America (POSN
Orthofix Medical (NASDAQ:OFIX) affirms FY2026 sales outlook from $850.000 million-$860.000 million t
Orthofix Medical (NASDAQ:OFIX) reported quarterly losses of $(0.13) per share which beat the analyst
Company Reports Preliminary First Quarter 2026 Net Sales and Reaffirms 2026 OutlookOrthofix Medical
Stifel analyst Thomas Stephan maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the
Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and
Orthofix Medical (NASDAQ:OFIX) sees FY2026 sales of $850.000 million-$860.000 million vs $862.758 mi
Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.24 per share which beat the analyst
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outpe
TD Cowen analyst Mathew Blackman initiates coverage on Orthofix Medical (NASDAQ:OFIX) with a Hold